NLE Cardiovascular Nursing — Cardiovascular Assessment and DiagnosticsStudy Notes

Understanding cardiac physiology is the prerequisite for meaningful cardiovascular assessment. The heart is a four-chambered muscular pump designed to circulate blood and deliver oxygen-rich blood to all body tissues. Blood flow follows a predictable pathway: deoxygenated blood from the systemic circulation returns to the right atrium via the superior and inferior vena cava. This blood passes through the tricuspid valve into the right ventricle and is then pumped through the pulmonic valve into the pulmonary artery, where it travels to the lungs for oxygenation. The oxygenated blood returns via the pulmonary veins to the left atrium, passes through the mitral valve (also called the bicuspid valve) into the left ventricle, and is forcefully ejected through the aortic valve into the aorta for systemic distribution. Cardiac Output (CO) is the amount of blood ejected by the heart per minute and is typically 4–8 L/min in a resting adult. This critical hemodynamic parameter is calculated using the formula: **CO = Heart Rate (HR) × Stroke Volume (SV)**. Understanding this relationship is crucial because it shows that cardiac output can be affected by changes in either heart rate or stroke volume. Stroke volume depends on three essential factors—the "cardiac triad": 1. **Preload**: The volume of blood in the ventricle at the end of diastole, reflecting venous return to the heart. This concept is governed by the Frank-Starling Law, which states that increased ventricular filling (within physiologic limits) stretches the myocardial fibers, resulting in stronger contraction and increased stroke volume. In clinical practice, when patients develop heart failure or fluid overload, excessive preload leads to pulmonary edema. Conversely, hypovolemia from dehydration or hemorrhage decreases preload, reducing stroke volume and cardiac output. 2. **Afterload**: The resistance the ventricle must overcome to eject blood against systemic vascular resistance (SVR). Hypertension increases afterload because the heart must work harder to push blood into a high-resistance system. Over time, chronically elevated afterload leads to left ventricular hypertrophy and heart failure. Medications like vasodilators are used therapeutically to reduce afterload in heart failure management. 3. **Contractility**: The inherent ability of the myocardial muscle to generate force and shorten, independent of preload and afterload. Contractility is influenced by sympathetic nervous system activity, electrolyte balance (particularly calcium and magnesium), and the presence of myocardial damage or disease. Positive inotropes (such as dopamine and dobutamine) enhance contractility, while negative inotropes (like beta-blockers) decrease contractility. The electrical conduction system initiates and coordinates heart contraction. The **sinoatrial (SA) node**, located in the right atrial wall near the entry of the superior vena cava, serves as the heart's natural pacemaker. It spontaneously generates electrical impulses at a rate of 60–100 beats per minute (bpm) under normal conditions. The SA node is influenced by the autonomic nervous system: parasympathetic stimulation (via the vagus nerve) decreases the firing rate, while sympathetic stimulation increases it. From the SA node, electrical impulses travel across the atria, causing atrial depolarization and contraction, then converge at the **atrioventricular (AV) node**. The AV node normally delays impulse conduction by approximately 0.1 second, allowing the atria to complete contraction and fill the ventricles. This physiologic delay is critical—without it, the ventricles would contract before they are adequately filled. The electrical impulse then travels down the **bundle of His**, which divides into the **right and left bundle branches**, and terminates in the **Purkinje fibers** throughout the ventricular myocardium. This coordinated spread of electrical activity triggers synchronized ventricular contraction from the apex upward, optimizing the pumping action. Disruption at any point in this conduction pathway results in dysrhythmias ranging from benign to life-threatening.

A thorough cardiovascular health history is the foundation of nursing assessment and forms part of the comprehensive patient interview required under NCM (Nursing Care Management) protocols. When assessing patients for cardiovascular disease risk and current pathology, nurses must systematically gather information using validated frameworks. **Chief Complaint and Presenting Symptoms**: Begin by asking open-ended questions about the patient's primary concern. Key cardiovascular symptoms to explore include: - **Chest Pain/Discomfort**: Use the **PQRST framework** to characterize any chest discomfort. **P (Provocation/Palliating factors)**: What triggers the pain? What relieves it? (e.g., rest, antacids, position change). Does stress or exertion precipitate it? **Q (Quality)**: Ask the patient to describe the pain in their own words—crushing, squeezing, pressure, sharp, burning, or dull? **R (Region/Radiation)**: Where exactly is the pain located? Does it radiate to the arms, jaw, back, or shoulder? Left arm pain with chest discomfort is concerning for angina or MI. **S (Severity)**: Use a numeric pain scale (0–10) to grade severity. Severe pain warrants urgent evaluation. **T (Timing)**: When did it start? How long does it last? Is it constant or intermittent? Does it occur at specific times of day? - **Dyspnea (Shortness of Breath)**: Quantify the degree of exertion required to trigger dyspnea. Functional assessment is crucial: Can the patient climb one flight of stairs, or do they become breathless walking on level ground? **Orthopnea** (dyspnea when lying flat) and **paroxysmal nocturnal dyspnea (PND)**—sudden nighttime awakening with severe breathlessness—both suggest pulmonary edema from left heart failure. - **Palpitations**: Racing, fluttering, or pounding sensation in the chest suggests dysrhythmias. Ask: Are they regular or irregular? Do they occur at rest or with exertion? Do they provoke dizziness or syncope? - **Fatigue and Exercise Intolerance**: Decreased exercise capacity or persistent fatigue despite adequate rest may indicate reduced cardiac output from heart failure or coronary artery disease. - **Edema**: Peripheral swelling (especially in dependent areas like the ankles and feet) suggests right heart failure or venous insufficiency. Assess weight gain, which may indicate fluid retention. - **Syncope or Presyncope (Dizziness)**: Loss of consciousness or near-syncope with cardiac causes (dysrhythmias, aortic stenosis) is a red flag requiring urgent evaluation. **Cardiovascular Risk Factors**: Systematically assess and document all relevant risk factors. The major modifiable risk factors include: - **Hypertension**: Elevated blood pressure is the most prevalent cardiovascular risk factor in the Philippines. Ask current BP readings and whether the patient takes antihypertensive medications. - **Dyslipidemia**: Abnormal cholesterol and triglyceride levels increase atherosclerotic risk. Inquire about recent lipid profiles and dietary intake. - **Diabetes Mellitus**: Hyperglycemia accelerates atherosclerosis. Assess glycemic control and current medications. - **Smoking**: Tobacco use damages the endothelium and increases thrombotic risk. Document current status and pack-years of smoking history. - **Obesity**: Body mass index (BMI) ≥ 30 kg/m² increases cardiovascular strain. Calculate BMI from height and weight. - **Sedentary Lifestyle**: Physical inactivity increases risk. Assess current activity level and exercise frequency. - **Stress and Mental Health**: Psychological stress and depression are independent risk factors. Screen for depression using validated tools. Non-modifiable risk factors include age (risk increases with age), male sex (or postmenopausal female status), and **family history of premature cardiovascular disease** (early MI or sudden death in first-degree relatives before age 55 in men or 65 in women). This information aligns with the DOH Philippines Package of Essential NCD Interventions (PhilPEN), which prioritizes cardiovascular risk assessment in primary care settings and in all healthcare encounters. Nurses in barangay health centers and rural clinics are often the first point of contact for risk factor screening and health education.

Physical examination of the cardiovascular system requires a systematic, head-to-toe approach combined with targeted assessment of the heart and peripheral circulation. The examination is typically performed with the patient supine and at a 30–45-degree angle, which optimizes visualization of jugular veins and allows the nurse to observe the entire precordium. **General Inspection**: Begin by observing the patient's overall appearance, skin color, and respiratory effort. Look for signs of cardiovascular compromise: - **Cyanosis**: A bluish discoloration of the skin and mucous membranes indicating inadequate oxygenation. **Central cyanosis** (blue lips, tongue, or trunk) reflects low arterial oxygen saturation and suggests significant cardiac or pulmonary disease. **Peripheral cyanosis** (blue fingertips and toes) may indicate poor peripheral perfusion from low cardiac output or vasoconstriction. - **Clubbing**: Bulbous enlargement of the fingertips and toenails occurring with chronic hypoxemia from prolonged right-to-left shunting (as in cyanotic heart disease) or chronic lung disease. The normal angle between the nail bed and finger becomes >180 degrees (lost nail bed angle). - **Pallor**: Pale skin may indicate anemia, which reduces oxygen-carrying capacity and forces the heart to work harder (high-output stress). **Jugular Venous Assessment**: The jugular veins (internal and external) reflect central venous pressure (CVP) and right atrial preload. With the patient reclined at 45 degrees, observe the internal jugular vein along the sternocleidomastoid muscle. Estimate the **jugular venous pressure (JVP)** by measuring the vertical distance from the angle of Louis (sternal angle, the level of the 2nd rib) to the highest point of visible venous pulsation. Normal JVP is ≤4 cm of water above the sternal angle. **Jugular venous distention (JVD)** (visibly prominent or distended neck veins) >4 cm suggests elevated CVP from right heart failure, fluid overload, or impaired venous return (e.g., superior vena cava syndrome). Conversely, flat neck veins suggest hypovolemia. To differentiate the internal jugular vein (which has pulsatile flow) from the external jugular vein (which is nonpulsatile), apply gentle pressure at the base of the neck; the internal jugular vein will collapse distally, while the external will not. **Peripheral Edema and Fluid Status**: Inspect the lower extremities, sacrum (in bedridden patients), and any dependent areas for edema. Press firmly over the tibia for 5 seconds; if an indentation remains after release, **pitting edema** is present. Grade it: 1+ (slight indentation, resolves quickly), 2+ (indentation remains 1–2 seconds), 3+ (indentation remains >2 seconds), or 4+ (deep indentation remaining >5 seconds). Significant bilateral peripheral edema suggests systemic fluid overload from heart failure or severe malnutrition (low albumin). **Pulse Assessment**: Palpate all major pulses systematically: temporal, carotid, apical, radial, femoral, popliteal, dorsalis pedis, and posterior tibial. For each pulse, assess: - **Rate**: Count beats per minute; normal is 60–100 bpm. - **Rhythm**: Regular, regularly irregular (e.g., premature beats in a pattern), or irregularly irregular (suggesting atrial fibrillation). - **Amplitude (Strength)**: Grade on a scale: 0 = absent, 1+ = diminished, 2+ = normal, 3+ = bounding, 4+ = very bounding. A diminished pulse suggests reduced stroke volume; a bounding pulse may indicate increased stroke volume (fever, anemia, thyrotoxicosis) or aortic regurgitation. - **Symmetry**: Compare pulses on both sides; asymmetry may indicate arterial stenosis or occlusion. **Capillary Refill**: Press firmly on a fingertip or toenail bed for 5 seconds, then release. Normal capillary refill is <3 seconds; prolonged refill (>3 seconds) indicates poor peripheral perfusion, possible shock, or severe anemia. **Point of Maximal Impulse (PMI)**: The PMI (also called the apical impulse) is the point where the left ventricular contraction is most forcefully felt. In a healthy adult, the PMI is located at the **5th intercostal space at the midclavicular line** and measures no more than 1–2 cm in diameter. With the patient supine or in slight left lateral decubitus position, use light palpation to locate the PMI. A PMI that is displaced laterally (beyond the midclavicular line) or inferiorly (below the 5th space) suggests left ventricular enlargement from chronic hypertension or cardiomyopathy. A diffuse or "heaving" PMI (hyperkinetic impulse) suggests hyperdynamic circulation (anemia, fever) or increased contractility. An absent or difficult-to-palpate PMI may occur in obese patients, emphysema, or when the patient is tachycardic.

Auscultation of heart sounds is a fundamental assessment skill that requires practice, a quiet environment, and a systematic approach. The stethoscope has two earpieces: the **diaphragm** (flat, larger surface for high-pitched sounds) and the **bell** (smaller, curved for low-pitched sounds). Use the diaphragm for S1, S2, murmurs, and clicks; use the bell for S3, S4, and rubs. **Valvular Landmarks and Systematic Auscultation**: Heart sounds best audible over specific areas on the chest wall. The mnemonic **APE To Man** helps remember the valve auscultation sites (aortic, pulmonic, Erb's point, tricuspid, mitral/apex). More precisely: - **Aortic area**: 2nd intercostal space, right of the sternal border (aortic valve closure). - **Pulmonic area**: 2nd intercostal space, left of the sternal border (pulmonic valve closure). - **Erb's point**: 3rd intercostal space, left of the sternal border (where aortic and pulmonic sounds blend; useful for detecting murmurs). - **Tricuspid area**: 4th intercostal space, left of the sternal border or lower left sternal border (tricuspid valve). - **Mitral/Apical area**: 5th intercostal space, midclavicular line (mitral valve; loudest location for S1 and apical pathology). Auscultate in a systematic sequence, moving from the aortic area downward to the apex, listening first at each area with the diaphragm, then with the bell. Listen through at least one complete cardiac cycle at each location. Have the patient sit up and lean forward to enhance sounds at the aortic area (aortic regurgitation). Have the patient lie in the left lateral decubitus position to enhance mitral area sounds and S3/S4 gallops. **Normal Heart Sounds**: - **S1 ("Lub")**: Represents closure of the atrioventricular (AV) valves—the mitral valve (left side) and tricuspid valve (right side)—at the onset of ventricular systole. S1 marks the beginning of systole. It is loudest at the apex (mitral area) where the mitral valve closure dominates. S1 is best heard with the diaphragm and is a single, sharp, high-pitched sound. Physiologic splitting of S1 (two distinct components) may occur normally. - **S2 ("Dub")**: Represents closure of the semilunar valves—the aortic valve and pulmonic valve—at the end of ventricular systole, marking the beginning of diastole. S2 is loudest at the base of the heart (aortic and pulmonic areas). **Physiologic splitting of S2** is normal; it widens during inspiration because pulmonary vascular capacitance increases, delaying pulmonic valve closure, while aortic valve closure remains relatively fixed. When you hear two distinct sounds during systole at the aortic area (A2, then P2 after a brief interval), this is normal. - **S3 (Ventricular Gallop)**: A low-pitched, dull sound heard early in diastole (just after S2), best appreciated with the bell at the apex in the left lateral decubitus position. S3 is normal in children and young adults (<30 years) and represents rapid ventricular filling. In older adults (>40 years), S3 is abnormal and is a classic sign of **left ventricular failure and volume overload**. The presence of S3 in an elderly patient warrants evaluation for heart failure. S3 produces a three-beat rhythm: **S1-S2-S3**, which sounds like "ken-tuck-y" (hence the term "ventricular gallop"). - **S4 (Atrial Gallop)**: A low-pitched sound heard immediately before S1 in late diastole, best heard with the bell at the apex. S4 represents atrial contraction forcing blood into a stiff, noncompliant ventricle. Common causes include left ventricular hypertrophy from chronic hypertension or aortic stenosis. S4 produces a rhythm: **S4-S1-S2**, which sounds like "ten-nes-see" (hence the term "atrial gallop"). S4 may be normal in athletic individuals with left ventricular hypertrophy. **Abnormal Heart Sounds and Murmurs**: - **Murmurs**: Abnormal heart sounds caused by turbulent blood flow through narrowed or regurgitant valves. Murmurs are characterized by their **timing** (systolic or diastolic), **location**, **quality** (soft, harsh, musical), **radiation**, and **grade**. The **Levine scale** grades murmurs from **I to VI**: I (barely audible, requiring careful listening), II (quiet but immediately audible), III (moderately loud), IV (loud with a palpable thrill), V (very loud and audible with stethoscope partially off the chest), and VI (audible without stethoscope). - **Systolic murmurs**: Occur during ventricular systole (between S1 and S2). *Innocent systolic murmurs* are common in children, during fever, anemia, or pregnancy, and in athletes; they are soft, short, localized, and without associated symptoms. **Pathologic systolic murmurs** include aortic stenosis (harsh, loudest at the right upper sternal border, radiates to the carotid arteries) and mitral regurgitation (high-pitched, holosystolic or pansystolic, loudest at the apex, radiates to the axilla). - **Diastolic murmurs**: Occur during diastole and are usually pathologic. Aortic regurgitation produces an early diastolic, high-pitched, blowing murmur best heard with the patient sitting forward. Mitral stenosis produces a mid-diastolic, low-pitched, rumbling murmur best heard at the apex with the patient in left lateral decubitus. - **Pericardial Friction Rub**: A grating, squeaking sound best heard with the patient sitting forward and leaning toward the left. It occurs in pericarditis when the inflamed pericardial surfaces rub against each other. The rub may have three components (atrial systole, ventricular systole, ventricular diastole), making it highly characteristic. It is louder with inspiration and patient leaning forward. **Clinical Pearls for Auscultation**: Always auscultate in a systematic manner, in a quiet environment, and in multiple positions. Listen for the rate and rhythm of sounds, the presence of extra sounds (S3, S4), and any murmurs. Remember that patient anxiety or fever can increase the heart rate and accentuate flow murmurs. Obese patients or those with chronic obstructive pulmonary disease may have diminished heart sounds. Integration of auscultatory findings with clinical history and other assessment data improves diagnostic accuracy.

The electrocardiogram (ECG or EKG) is a graphic recording of the electrical activity of the heart and is one of the most important diagnostic tools in cardiology. It is noninvasive, rapid, inexpensive, and universally available. The ECG machine records electrical voltage (vertical axis, in millivolts) over time (horizontal axis, in seconds) on standardized graph paper. **ECG Paper and Timing**: Standard ECG graph paper has small boxes and large boxes: - **Each small box** = 0.04 second (40 milliseconds). - **Each large box** (composed of 5 small boxes) = **0.20 second** (200 milliseconds). - **One second of recording** = 5 large boxes or 25 small boxes. This timing is critical for calculating heart rate, measuring intervals, and diagnosing dysrhythmias. **ECG Leads and Views**: The standard 12-lead ECG provides 12 different views of the heart's electrical activity: - **Frontal plane leads** (I, II, III, aVR, aVL, aVF): Show left-right and superior-inferior cardiac electrical activity. Lead II is often used for rhythm strips because it clearly shows P waves and the PR interval. - **Horizontal plane (precordial) leads** (V1–V6): Show anterior-posterior and right-left cardiac activity and localize ventricular pathology. For the purposes of basic rhythm interpretation, a single lead (typically II or a rhythm strip) is often sufficient to determine rate and rhythm. **ECG Waveform Components**: - **P Wave**: Represents **atrial depolarization** (the electrical impulse traveling through the atria, causing them to contract). The P wave should be upright in leads II and aVF, and upright or biphasic in lead V1. Normal P wave duration is <0.12 second (3 small boxes). An abnormal P wave (peaked, prolonged, or deeply biphasic) suggests atrial enlargement. - **PR Interval**: Measured from the **beginning of the P wave to the beginning of the QRS complex**. It represents conduction time from the SA node through the atria, AV node, bundle of His, and bundle branches. Normal PR interval is **0.12–0.20 second** (3–5 small boxes). **PR prolongation (>0.20 second)** indicates delayed AV nodal conduction (first-degree AV block). **PR shortening (<0.12 second)** may suggest pre-excitation (Wolff-Parkinson-White syndrome). - **QRS Complex**: Represents **ventricular depolarization**. The Q wave (if present) is the initial negative (downward) deflection; the R wave is the first positive (upward) deflection; the S wave is the negative deflection after the R wave. The **normal QRS duration is 0.06–0.10 second** (1.5–2.5 small boxes). A **wide QRS (≥0.12 second or ≥3 small boxes)** suggests a ventricular origin of the rhythm (ventricular ectopy) or a bundle branch block. In bundle branch blocks, the impulse is not conducted through the normal conduction system but instead spreads slowly through the ventricular muscle, creating a widened, often notched QRS complex. - **ST Segment**: The **isoelectric period after the QRS** (from the J point where the QRS ends to the beginning of the T wave). The ST segment should normally be at the baseline (isoelectric). **ST segment elevation** (typically ≥1 mm in two contiguous leads) is a hallmark of acute myocardial injury and indicates **ST-elevation MI (STEMI)** and requires emergent reperfusion therapy. **ST segment depression** (also ≥1 mm) indicates **myocardial ischemia** and warrants urgent evaluation. - **T Wave**: Represents **ventricular repolarization** (the period when the ventricular muscle recovers and is ready for the next impulse). The T wave is normally upright in most leads (except aVR) and has a gentle slope. **Inverted T waves** suggest **myocardial ischemia** or infarction. **Tall, peaked T waves** (>5 mm) suggest **hyperkalemia** (elevated serum potassium), which is a medical emergency because it increases the risk of life-threatening dysrhythmias. **Flattened T waves** may indicate hypokalemia or ischemia. - **QT Interval**: Measured from the **beginning of the QRS to the end of the T wave**, representing the total duration of **ventricular depolarization and repolarization**. Normal QT interval varies by heart rate (faster rates have shorter QT intervals). **QT prolongation** increases the risk of **torsades de pointes**, a dangerous polymorphic ventricular dysrhythmia. Causes include antiarrhythmic drugs, electrolyte abnormalities (low potassium, magnesium, calcium), and congenital long QT syndrome. **Determining Heart Rate from the ECG**: Several methods can calculate heart rate: 1. **Six-Second Rule**: Count the number of QRS complexes (or R-R intervals) in a 6-second strip and multiply by 10. (Most ECG strips are printed with 6-second markers.) 2. **Large Box Method**: Count the number of large boxes between two consecutive R waves and divide 300 by this number. - 1 large box = 300 bpm - 2 large boxes = 150 bpm - 3 large boxes = 100 bpm - 4 large boxes = 75 bpm - 5 large boxes = 60 bpm - 6 large boxes = 50 bpm 3. **Small Box Method**: Count the number of small boxes between R waves and divide 1500 by this number. This is more accurate but more tedious. Normal heart rate is **60–100 bpm**. **Bradycardia** is <60 bpm; **tachycardia** is >100 bpm. **Systematic ECG Interpretation**: When presented with an ECG, always follow a systematic approach: 1. **Rate**: Using the methods above, calculate and document the ventricular rate. Is it normal, fast, or slow? 2. **Rhythm**: Is the rhythm **regular** (consistent R-R intervals), **regularly irregular** (a pattern of irregularity, such as premature beats occurring every few beats), or **irregularly irregular** (completely random R-R intervals, as in atrial fibrillation)? 3. **P Wave**: Is there a P wave? Is there one P wave before each QRS complex (1:1 relationship)? Are P waves upright, inverted, or absent? If P waves are absent, is the rhythm supraventricular or ventricular? 4. **PR Interval**: Measure the PR interval in any lead with a visible P wave. Is it normal (0.12–0.20 sec), prolonged (>0.20 sec suggesting AV block), or short (<0.12 sec)? 5. **QRS Duration**: Measure and classify. Is it narrow (<0.12 sec) indicating supraventricular origin, or wide (≥0.12 sec) suggesting ventricular origin or bundle branch block? 6. **ST Segment**: Is the ST segment at baseline, elevated, or depressed? In which leads? Elevation in leads II, III, and aVF indicates inferior MI; elevation in V1–V4 indicates anterior MI. 7. **T Wave**: Are T waves normal, inverted, peaked, or flattened? In which leads? 8. **Other Findings**: Look for U waves, Q waves (>0.04 sec width and >1/3 the R wave height may indicate old MI), unusual electrical axis, or other abnormalities. **Normal Sinus Rhythm (NSR)**: The gold standard for a normal, healthy rhythm is normal sinus rhythm: - **Rate**: 60–100 bpm - **Rhythm**: Regular (consistent R-R intervals) - **P wave**: One upright P wave precedes each QRS - **PR interval**: Normal (0.12–0.20 sec) - **QRS duration**: Normal and narrow (<0.12 sec) **Clinical Significance of ECG Findings for Nurses**: While comprehensive ECG interpretation requires physician expertise, nurses must recognize critical findings requiring immediate action: **ST elevation** (STEMI—call code/activate chest pain protocol), **ST depression with chest pain** (unstable angina or NSTEMI), **peaked T waves** (hyperkalemia—notify provider immediately), **prolonged QT interval** (risk of torsades de pointes), **bradycardia <40 bpm** (may require pacing), **tachycardia >150 bpm** (may indicate atrial fibrillation with rapid ventricular response, supraventricular tachycardia, or ventricular tachycardia), and **wide QRS complexes with altered consciousness** (possible ventricular tachycardia—prepare for emergency interventions). Always correlate ECG findings with clinical symptoms and provider judgment.

Cardiac biomarkers are proteins released into the bloodstream when myocardial cells are damaged or stressed. They are essential diagnostic tools for identifying myocardial infarction (MI), stratifying risk, and monitoring the efficacy of reperfusion therapy. Nurses must understand the kinetics (rise, peak, and clearance times) of these markers and their clinical interpretation. **Troponins (Troponin I and Troponin T)**: The **Gold Standard for Myocardial Injury** Cardiac troponins are regulatory proteins on the thin filaments of myocardial sarcomeres. When myocardial cells undergo necrosis or apoptosis, troponins are released into the circulation. Troponin is highly **cardiac-specific** (minimal skeletal muscle cross-reactivity) and highly **sensitive** for myocardial damage. - **Normal Reference Range**: Troponin I is typically **<0.04 ng/mL** (laboratory-specific ranges vary; always check your institution's reference range). Troponin T has similar cutoffs. - **Kinetics**: Troponin begins rising in the blood **3–6 hours after myocardial injury**, peaks around **12–24 hours** after injury, and remains elevated for up to **10–14 days**. This extended elevation window is advantageous for detecting MIs that occurred several days prior but challenging if the clinician is trying to distinguish a new MI from an old one. - **Clinical Application**: In the setting of acute coronary syndrome (ACS), troponin is measured on admission and then **repeated at 3 hours** (or at 2 hours with high-sensitivity troponin assays). A rise and/or fall in serial troponin levels (along with clinical symptoms and ECG findings) confirms acute MI. The absence of troponin elevation at 3 hours, combined with a normal admission troponin and no ischemic ECG changes, makes acute MI very unlikely (negative predictive value >99%). - **Critical Clinical Pearl**: The **absolute value of troponin matters less than the trend**. A patient with troponin of 0.08 ng/mL on admission and 0.12 ng/mL at 3 hours shows a rising trend indicating acute MI, even though individual values might be only mildly elevated. **Creatine Kinase-MB (CK-MB)**: The Cardiac Fraction of CK CK-MB is the cardiac-specific isoenzyme of creatine kinase. While CK-MB is less specific than troponin (because some CK-MB can originate from skeletal muscle, especially with muscle injury or rhabdomyolysis), it has different kinetics: - **Kinetics**: CK-MB rises **3–6 hours** after MI, peaks at **12–24 hours**, and returns to normal in **2–3 days**. Because it clears faster than troponin, CK-MB is useful for detecting **reinfarction** (a second MI occurring shortly after the first). When a patient has had an MI and CK-MB has normalized, a second elevation indicates a new infarction. - **Reference Range**: Normal CK-MB is typically **<5 ng/mL** or **<5% of total CK**. **Myoglobin**: Early but Not Cardiac-Specific Myoglobin is a protein found in both cardiac and skeletal muscle. It is released rapidly (within 1–3 hours) after muscle injury, making it the earliest marker of myocardial infarction. However, it is **not cardiac-specific**; elevated myoglobin can also result from skeletal muscle injury, trauma, or intense exercise. - **Clinical Use**: A **negative myoglobin at admission helps rule out recent MI** because if MI occurred >3 hours ago, myoglobin should be elevated. However, a positive myoglobin does not confirm MI; it only indicates muscle injury somewhere in the body. Myoglobin is less commonly used today, having been largely replaced by high-sensitivity troponin assays. **B-Type Natriuretic Peptide (BNP) and N-Terminal Pro-BNP (NT-proBNP)**: Markers of Ventricular Stress and Heart Failure BNP is a 32-amino-acid peptide hormone synthesized by ventricular myocytes in response to ventricular stretch and volume/pressure overload. NT-proBNP is the inactive N-terminal fragment produced when BNP is synthesized. - **Clinical Significance**: Elevated BNP or NT-proBNP indicates ventricular dysfunction and is used to **diagnose and stage heart failure**. In the acute dyspneic patient, BNP helps differentiate cardiac from noncardiac causes of dyspnea. - **Cutoff Values**: - **BNP <100 pg/mL** makes acute decompensated heart failure **very unlikely** (high negative predictive value). - **BNP 100–500 pg/mL** is in the "gray zone" and warrants clinical correlation. - **BNP >500 pg/mL** is consistent with heart failure, though elevation can also occur with renal failure, atrial fibrillation, sepsis, and pulmonary embolism. - **Nursing Application**: When caring for a dyspneic patient without clear etiology, BNP can help guide diagnostic workup. A low BNP (<100) suggests heart failure is not the cause and directs investigation toward pulmonary or other etiologies. A high BNP in the setting of orthopnea, peripheral edema, and crackles on lung exam confirms heart failure diagnosis. **Other Relevant Cardiac and Risk Assessment Labs**: - **Lipid Panel**: Total cholesterol, LDL ("bad" cholesterol), HDL ("good" cholesterol), and triglycerides. Used for cardiovascular risk stratification per Philippine DOH guidelines. Optimal values: total cholesterol <200 mg/dL, LDL <100 mg/dL, HDL >40 mg/dL (males) or >50 mg/dL (females), triglycerides <150 mg/dL. - **High-Sensitivity C-Reactive Protein (hsCRP)**: A marker of systemic inflammation associated with atherosclerotic burden and cardiovascular risk. Elevated hsCRP (>3 mg/L) indicates increased cardiovascular risk. - **Electrolytes (Potassium, Magnesium, Calcium)**: Essential for cardiac electrical stability. Abnormalities predispose to dysrhythmias: - **Hyperkalemia** (K >5.5 mEq/L): Peaked T waves, prolonged PR, wide QRS → risk of ventricular fibrillation. - **Hypokalemia** (K <3.5 mEq/L): Flattened T waves, U waves, ST depression, prolonged QT → risk of torsades de pointes. - **Hypermagnesemia and hypocalcemia**: Prolong QT interval. - **Renal Function (Creatinine, Blood Urea Nitrogen)**: Important because contrast-induced nephropathy can occur after cardiac catheterization, and renal disease increases cardiovascular risk. - **Hemoglobin and Hematocrit**: Anemia increases cardiac workload and can precipitate or worsen angina and heart failure. **Nursing Responsibilities with Biomarker Testing**: - Ensure appropriate specimen collection (timing, volume, tube type per laboratory protocol). - Communicate the urgency of stat results to the laboratory when acute MI is suspected. - Understand that a single troponin value does not exclude MI; serial measurement (admission and 3 hours) is the standard. - Monitor for critical values and report immediately to the provider (e.g., troponin >0.4 ng/mL, potassium <2.5 or >6.5 mEq/L, BNP >1000 pg/mL). - Use lab results to guide nursing interventions (e.g., if hyperkalemic, restrict potassium intake, prepare for ECG monitoring, anticipate calcium gluconate and insulin + glucose administration). - Educate patients on the importance of fasting before lipid panels and on lifestyle modifications to improve lipid profiles (diet, exercise, smoking cessation).

Hemodynamic monitoring involves the use of invasive vascular catheters to directly measure cardiac pressures, volumes, and derived parameters. This advanced assessment is typically performed in critical care settings (ICU, operating room, catheterization laboratory) to guide treatment in unstable or complex patients. Understanding hemodynamic monitoring is essential for nurses caring for critically ill cardiovascular patients and is frequently tested in the NLE. **Central Venous Pressure (CVP) Monitoring**: A **central venous catheter (CVC)** is placed percutaneously or via cutdown into a large vein (typically the internal jugular, subclavian, or femoral vein) and threaded into the right atrium or superior vena cava. The CVP catheter is connected to a pressure transducer and continuous monitor to measure right atrial pressure in real time. - **Normal CVP**: **2–8 mmHg** (or 2–8 cm H₂O, depending on unit of measurement). Some sources cite 0–8 mmHg. - **Clinical Interpretation**: - **Low CVP (<2 mmHg)**: Suggests **hypovolemia** (dehydration, hemorrhage, third spacing). The right ventricle is underfilled, and preload is inadequate. Nursing interventions include fluid resuscitation, encouraging oral intake, and reviewing medication list for diuretics. - **High CVP (>8 mmHg)**: Suggests **hypervolemia** (fluid overload) or **right heart failure**. The right ventricle cannot pump blood forward effectively, causing blood to back up into the systemic venous system, raising right atrial pressure. Nursing interventions include fluid restriction, diuretics, and assessment for peripheral edema and JVD. - **Waveform Analysis**: The CVP waveform displays three positive waves (a, c, v) and two descents (x, y) reflecting the mechanical events of the cardiac cycle. Abnormal waveforms can indicate pathology (e.g., absent a wave in atrial fibrillation, cannon a waves in AV dissociation). **Pulmonary Artery (Swan-Ganz) Catheterization**: A **pulmonary artery catheter (PAC)**, or Swan-Ganz catheter, is a multi-lumen, thermodilution catheter inserted through the right heart into the pulmonary artery. It provides more comprehensive hemodynamic data than CVP alone, including pulmonary artery pressures, pulmonary artery wedge pressure (PAWP—a reflection of left ventricular preload), and cardiac output. - **Pulmonary Artery Pressure (PAP)**: - **Systolic PA pressure**: Normal **15–30 mmHg**; elevated in pulmonary hypertension or left heart failure. - **Diastolic PA pressure**: Normal **8–15 mmHg**. - **Mean PA pressure**: Normal **10–20 mmHg**. - **Pulmonary Artery Wedge Pressure (PAWP)** (also called pulmonary capillary wedge pressure or PCWP): - **Normal PAWP**: **8–12 mmHg** (reflects left ventricular end-diastolic pressure). - **Elevated PAWP (>12 mmHg)**: Indicates **left ventricular dysfunction**, **left-sided heart failure**, or **mitral stenosis**. High PAWP with dyspnea, crackles, and orthopnea indicates pulmonary edema. - **Low PAWP (<8 mmHg)**: Suggests **hypovolemia** and inadequate preload. - **Cardiac Output (CO)**: - Measured by **thermodilution**: Ice-cold saline is injected into the right atrium; the catheter measures the time and temperature change as blood carrying the saline reaches the pulmonary artery. The computer calculates CO based on this thermal washout. - **Normal CO**: **4–8 L/min** in an adult at rest. - **Cardiac Index (CI)**: CO adjusted for body surface area (BSA). **Normal CI: 2.5–4 L/min/m²**. CI is preferred over CO for comparing hemodynamics across patients of different sizes. - **Systemic Vascular Resistance (SVR)**: - Derived from pressures and CO: **SVR = [(MAP – CVP) × 80] / CO**. - **Normal SVR**: **800–1200 dyne·sec·cm⁻⁵**. - **High SVR**: Indicates **vasoconstriction** (shock states, excessive catecholamine use). - **Low SVR**: Indicates **vasodilation** (septic shock, anaphylaxis). **Arterial Line (A-Line) Monitoring**: An **arterial catheter** is placed percutaneously in a major artery (typically radial, but also femoral, dorsalis pedis, or brachial in emergencies). It provides: - **Continuous, direct blood pressure monitoring** with beat-to-beat accuracy. - **Mean arterial pressure (MAP)** automatically calculated. - **Access for frequent arterial blood gas (ABG) sampling** without repeated needle sticks. **Mean Arterial Pressure (MAP)**: MAP is the average pressure during the entire cardiac cycle and is the driving pressure that perfuses vital organs. **Formula**: **MAP = [Systolic + 2(Diastolic)] / 3** For example, if systolic BP is 120 and diastolic is 80: MAP = (120 + 160) / 3 = 93 mmHg. - **Clinical Significance**: A **MAP of at least 65 mmHg** is generally required to maintain adequate perfusion of vital organs (brain, heart, kidneys). In septic shock or severe hypotension, maintaining MAP >65 mmHg is a primary therapeutic goal. If MAP falls below 60 mmHg, tissue hypoxia and organ failure ensue. **Nursing Responsibilities in Hemodynamic Monitoring**: 1. **Transducer Leveling and Zeroing**: - Before each use and whenever the patient position changes, the **transducer must be leveled and zeroed** at the **phlebostatic axis**: the 4th intercostal space at the midaxillary line. This point corresponds to the level of the right atrium and ensures accurate pressure readings. - **Leveling**: Position the transducer at the phlebostatic axis using a carpenter's level or the bed's alignment marks. - **Zeroing (Calibration)**: Open the transducer to atmospheric air, press "zero" on the monitor, and confirm that the display reads 0 mmHg. This establishes the reference point. 2. **Waveform Assessment**: - Continuously monitor the waveform quality on the bedside monitor. Ensure adequate amplitude and clarity. - Damped or absent waveforms indicate catheter malposition, kinks, clots, or air bubbles in the line. Troubleshoot by checking tubing for kinks, aspirating for clots, and repositioning the catheter. - Normal waveforms fluctuate with respirations (waveforms typically rise slightly during expiration and fall during inspiration due to intrathoracic pressure changes). 3. **Aseptic Technique and Site Care**: - Maintain strict aseptic technique during insertion and ongoing care to prevent **catheter-related bloodstream infection (CRBSI)**. - Assess the insertion site regularly for signs of infection: erythema, warmth, drainage, or induration. If infection is suspected, notify the provider immediately—the catheter may need removal and culture. - Keep the site clean, dry, and covered with sterile dressing. - Per institutional protocol, replace dressings (typically every 2–3 days or if soiled/loose) and change the flush solution container (typically every 24 hours). - Monitor the duration of catheter placement; many institutions remove central lines after 7 days if no longer necessary. 4. **Monitoring and Documentation**: - Record pressures at regular intervals (typically hourly or per protocol) and with any significant clinical changes. - Document CVP, PA systolic/diastolic/mean, PAWP, CO, and CI. - Correlate hemodynamic values with clinical findings: Is the patient hypotensive despite high CVP (suggesting right heart failure)? Is PAWP elevated with crackles and orthopnea (indicating pulmonary edema)? These correlations guide clinical decision-making. 5. **Troubleshooting Common Issues**: - **Catheter whip (oscillating waveform)**: May indicate catheter tip touching vessel wall; reposition or flush. - **Clotted catheter**: Aspirate gently (do not force, as this could cause embolization); if unsuccessful, notify provider. - **Air bubble in line**: Compress and aspirate to remove; recheck waveform. - **Persistent dampening**: Verify transducer is at correct level and zeroed; check for kinks or clots; may require catheter repositioning or replacement. **Clinical Applications of Hemodynamic Data**: Hemodynamic monitoring guides fluid and vasoactive therapy titration. For example: - **Low CVP + low MAP + tachycardia**: Indicates hypovolemic shock; administer IV fluids (bolus). - **High CVP + high PAWP + low CO**: Indicates cardiogenic shock; may require inotropes (e.g., dobutamine to increase contractility) or vasodilators (e.g., nitroglycerin to reduce afterload). - **High SVR + low CO**: Vasoconstriction limiting cardiac output; use vasodilators. - **Low SVR + high CO**: Distributive shock (sepsis); may require vasopressors plus fluid resuscitation. These advanced hemodynamic assessments are typically in the purview of ICU nurses and critical care specialists, but all nurses should understand the principles and clinical implications.

**Cardiac catheterization** is an invasive diagnostic and therapeutic procedure in which a catheter is advanced through a peripheral artery or vein into the cardiac chambers and coronary arteries. It is the **gold standard for diagnosing coronary artery disease** and allows for direct visualization of coronary anatomy and hemodynamic assessment. When combined with **percutaneous coronary intervention (PCI)**, catheterization can include **angioplasty** (balloon dilation of stenotic vessels) and **stent placement** (deployment of a metallic mesh scaffolding to maintain vessel patency). Nurses play a crucial role in pre-procedure preparation, intra-procedure assistance (especially in catheterization labs), and post-procedure monitoring and patient education. **Indications for Cardiac Catheterization**: - Acute coronary syndrome (unstable angina, NSTEMI, STEMI) for diagnostic angiography and possible PCI/stenting. - Stable angina with evidence of significant ischemia on stress testing. - Evaluation of valvular heart disease severity (e.g., aortic stenosis gradient). - Assessment of ventricular function and hemodynamics in heart failure. - Evaluation of congenital heart disease. - Electrophysiology studies and ablation procedures. **Access Routes**: - **Arterial access** (most common): **Femoral artery** (larger vessel, easier puncture, but patient immobility post-procedure; more common); **Radial artery** (smaller vessel, steeper learning curve, but allows earlier ambulation and patient comfort). Other less common routes include brachial, ulnar, or axillary. - **Venous access** (for right heart catheterization or electrophysiology): **Femoral vein**, **internal jugular vein**, or **subclavian vein**. **Pre-Procedure Nursing Assessment and Patient Preparation**: Preparation is critical and begins during the office visit or admission to the hospital. Key interventions: 1. **Verify Informed Consent**: Ensure the patient and family understand the procedure, risks, benefits, and alternatives. The consent form must be signed and in the chart. 2. **Allergy Assessment (Critical)**: - **Iodine allergy**: Most cardiac contrast media contain iodine. An iodine allergy significantly increases the risk of anaphylaxis during the procedure. Ask: "Do you have an allergy to iodine, shellfish, or IV contrast dye?" - If allergy is confirmed or suspected, notify the cardiologist immediately. Precautions include: - Use of **low-osmolar or iso-osmolar contrast media** (safer than high-osmolar agents). - **Pre-medication protocol**: Administer corticosteroids (e.g., methylprednisolone 32 mg IV or oral prednisone) and H1 and H2 blockers (diphenhydramine + famotidine or ranitidine) 12 hours and 1 hour before the procedure. - Have **emergency medications on hand**: epinephrine, diphenhydramine, corticosteroids, and backup IV access. - **Non-iodine-based contrast** (e.g., gadolinium) is an alternative if iodine allergy is absolute. 3. **Renal Function Assessment**: - Obtain baseline **serum creatinine** and **blood urea nitrogen (BUN)**. Iodinated contrast is **nephrotoxic** and can cause **contrast-induced nephropathy (CIN)**, especially in patients with pre-existing renal impairment. - If creatinine is elevated (>1.5 mg/dL) or eGFR is low (<60 mL/min/1.73m²), notify the provider. Consider: - Use of iso-osmolar contrast (lower osmolarity reduces CIN risk). - **N-acetylcysteine (NAC) pre-medication**: Some institutions give NAC 600 mg PO twice daily for 2 days starting the day before the procedure (though evidence is mixed). - **Aggressive IV hydration** before and after the procedure with normal saline to dilute contrast and maintain renal perfusion. - Patients with diabetic nephropathy are at particularly high risk for CIN. 4. **Medication Review**: - Continue most cardiac medications (beta-blockers, ACE inhibitors, aspirin) as usual; confirm with provider. - **Hold** **metformin** 48 hours after the procedure (due to contrast/renal function interaction risk causing lactic acidosis). - **Hold** anticoagulants (warfarin, apixaban, rivaroxaban) per provider instruction; may transition to bridging heparin if patient has recent stent or high thrombotic risk. - Antiplatelet agents (aspirin, clopidogrel) are typically continued; dual antiplatelet therapy is essential after stent placement. 5. **NPO Status**: - Keep patient **NPO 6–8 hours** before the procedure (typically nothing after midnight if procedure is in the morning). This reduces aspiration risk if sedation is needed. 6. **Baseline Assessment**: - Document **baseline vital signs** (BP, HR, respirations, temperature, oxygen saturation). - **Mark and assess peripheral pulses distal to the planned insertion site** (femoral access: mark dorsalis pedis and posterior tibial pulses; radial access: mark radial and ulnar pulses). Document pulse quality (0–4+ grading), skin color, temperature, and sensation. These baseline findings are critical for post-procedure comparison to detect complications like bleeding or arterial dissection. - Perform a focused cardiovascular assessment: presence of murmurs, JVD, edema, auscultation of lungs. - Assess for anxiety and provide emotional support and education. 7. **Pre-Medication**: - Per provider order, may include: - **Anxiolytic**: diazepam or midazolam IV (light sedation; patient remains conscious and able to follow commands). - **Analgesic**: fentanyl or morphine IV for comfort. - These medications are titrated carefully to maintain hemodynamic stability and respiratory drive. **Intra-Procedure Nursing Responsibilities** (if assisting in the catheterization lab): - Assist with sterile draping and catheter insertion. - Monitor patient comfort, hemodynamics, and rhythm on the cardiac monitor. - Communicate with the cardiologist and assist as needed. - Prepare contrast media and other medications as directed. - Keep the patient calm and informed (e.g., "You may feel a warm, flushing sensation as the contrast is injected; this is normal. Tell me if you experience chest discomfort or shortness of breath."). - Watch the fluoroscopy monitor to observe catheter advancement and contrast injection; alert provider to any abnormalities. - Maintain vigilant observation for arrhythmias (ventricular ectopy during catheter manipulation is common; brief runs usually resolve with catheter repositioning). **Post-Procedure Nursing Care and Priority Interventions**: Post-procedure nursing care is critical for early detection of complications and patient safety. Priorities are ranked by Maslow's hierarchy: **Immediate Priority (Physiologic Safety)**: 1. **Assess the Insertion Site for Bleeding and Hematoma Formation**: - This is the **foremost priority** because bleeding or arterial rupture can lead to life-threatening hemorrhage or retroperitoneal bleeding (if femoral artery). - Immediately after procedure, check the site every **15 minutes for the first 1 hour**, then every **30 minutes for 2 hours**, then every **1 hour for 4 hours**, then every **4 hours or per protocol**. - Observe for: - **Active bleeding or oozing**: Apply direct pressure with sterile gauze; reinforce as needed. If bleeding is brisk or uncontrolled, notify the provider immediately. - **Hematoma** (localized bruising/swelling): Measure and document size. A hematoma <5 cm usually resolves without intervention; larger hematomas may require intervention or observation for pseudoaneurysm formation. - **Ecchymosis** (larger area of bruising): Document and monitor for expansion. - If significant bleeding persists, call the provider; interventions may include manual pressure, application of a hemostasis device (e.g., Angioseal), or ultrasound-guided compression. 2. **Check Distal Pulses and Peripheral Perfusion**: - Assess pulses distal to the insertion site **every 15–30 minutes for 2 hours**, then every 1–2 hours. - Compare with baseline: - **Dorsalis pedis and posterior tibial pulses** (femoral access). - **Radial and ulnar pulses** (radial access). - Assess for **"6 Ps"** of arterial insufficiency: 1. **Pain** in the extremity. 2. **Pallor** (pale skin color). 3. **Paresthesia** (numbness, tingling). 4. **Pulselessness** (diminished or absent pulses). 5. **Paralysis** or weakness (late sign, indicates severe ischemia). 6. **Poikilothermia** (cold to touch). - If any of these signs develops, **notify the provider immediately**; the artery may be thrombosed or dissected, requiring urgent intervention (possible intervention or surgery). 3. **Maintain Bed Rest and Extremity Position**: - For **femoral artery access**: Keep the **affected leg straight** (no bending at the hip/knee) for the prescribed period (typically 4–6 hours). Hip flexion increases pressure on the puncture site and increases bleeding risk. Elevate head of bed slightly (no more than 30 degrees) to minimize hip flexion strain. - For **radial artery access**: No specific position restrictions, though some protocols recommend keeping arm extended briefly after removal of hemostasis device. - Use a bed cradle or sandbag to keep the leg straight and reduce accidental flexion. - Assist with activities (toileting, positioning) to prevent patient from bending the affected leg. 4. **Apply Pressure or Hemostasis Device**: - After catheter removal, manual pressure is applied to the puncture site for **10–15 minutes** (or as ordered) until bleeding stops. - Many centers use **hemostasis devices** (e.g., **Angioseal**, **PerClose**, **ExoSeal**) that achieve hemostasis faster (within 5–10 minutes), allowing earlier ambulation (within 1–2 hours) compared to manual compression alone (4–6 hours immobility). - If a **pressure dressing** is applied, monitor for excessive tightness (check distal pulses and extremity color regularly) and for signs of bleeding that require reinforcement. 5. **Encourage Fluid Intake and Monitor Urine Output**: - Begin **oral fluids immediately** after procedure (assuming no nausea or contraindications); encourage **generous fluid intake** to flush out the contrast dye and maintain urine output, which protects the kidneys from contrast-induced nephropathy. - Goal: Urine output of at least **100–150 mL/hour** for several hours after the procedure. - Monitor for adequate renal perfusion: Ensure **systolic BP >90 mmHg** and urine output remains adequate. - **IV hydration** (normal saline) is often continued for several hours to ensure adequate intravascular volume and renal perfusion. **Monitoring for Complications**: 6. **Assess for Systemic Complications**: - **Chest pain**: New or recurrent chest pain may indicate **myocardial infarction**, **coronary dissection**, or **spasm**. Perform 12-lead ECG, assess troponin, and notify provider immediately. - **Dysrhythmias**: Atrial fibrillation, premature ventricular contractions, or other arrhythmias may occur secondary to contrast injection or manipulation. Monitor rhythm closely; notify provider if sustained or hemodynamically significant. - **Hypotension**: May indicate bleeding (external or retroperitoneal), sepsis (delayed), or vasovagal response. Assess for bleeding, check CVP if available, administer fluids as ordered, and notify provider. - **Contrast allergic reaction or anaphylaxis**: Rash, pruritus, wheezing, hypotension, angioedema. Have emergency medications and airway equipment available. Treat per protocol: discontinue contrast, elevate legs, administer epinephrine IM if severe, maintain airway, give IV fluids and oxygen as needed. This is a rare but serious complication. - **Contrast-induced nephropathy**: Acute kidney injury developing 24–72 hours after contrast exposure. Monitor creatinine and urine output. Risk factors: pre-existing renal disease, diabetes, advanced age, dehydration. Prevention: aggressive hydration, iso-osmolar contrast, avoidance of nephrotoxic drugs (e.g., NSAIDs, ACE inhibitors in some cases). 7. **Assess for Retroperitoneal Bleeding** (especially after femoral access): - Retroperitoneal bleeding is a serious, sometimes occult complication that can develop hours after the procedure. - Warning signs: - **Sudden-onset lower back or flank pain**. - **Abdominal pain or distention**. - **Hypotension and tachycardia** (signs of significant blood loss). - **Ecchymosis over lower abdomen** (late sign). - If suspected, notify the provider immediately. CT angiography may be performed for confirmation. Treatment ranges from observation (small bleeds) to blood transfusion, reversal of anticoagulation, or interventional radiology/surgical intervention for larger bleeds. 8. **Neurologic Assessment**: - Monitor for **stroke** (arm or leg weakness, facial drooping, speech difficulty) or **transient ischemic attack (TIA)**, which can result from catheter-induced embolization or dissection of the carotid or vertebral arteries (rare but serious). Report any neurologic changes immediately. **Discharge Planning and Patient Education** (4–6 hours post-procedure if uncomplicated): Provide clear, written instructions: - **Wound Care**: Keep the insertion site clean and dry. Shower in 24 hours; avoid tub soaking initially. Do not apply lotions or creams to the site. Report any signs of infection (increased redness, warmth, drainage, fever). - **Activity Restrictions**: No heavy lifting, strenuous exercise, or driving for 48 hours (or per provider instruction). Gradually resume normal activities over a few days. - **Fluid Intake**: Continue drinking plenty of water and fluids for 48 hours to clear the contrast and protect kidneys. Discourage alcoholic beverages temporarily. - **Medications**: - Continue aspirin and other cardiac medications as prescribed. - If a **stent** was placed, dual antiplatelet therapy (typically aspirin + clopidogrel, ticagrelor, or prasugrel) is essential for ≥12 months (or longer for some stent types) to prevent stent thrombosis. Emphasize compliance. - Resume **metformin** after 48 hours if held. - **Signs/Symptoms Requiring Immediate Evaluation**: - Bleeding from the insertion site (if can't be controlled with direct pressure). - Increasing swelling, redness, or drainage at the site. - Numbness, coldness, or color change in the extremity. - Chest pain, severe dyspnea, or palpitations. - Fever (>38°C). - Severe back or abdominal pain. - Any other concerning symptoms. - **Cardiovascular Risk Factor Modification** (aligned with DOH PhilPEN): Reinforce the importance of: - **Blood Pressure Control**: Monitor at home; take antihypertensives as directed. - **Smoking Cessation**: Absolute imperative after coronary angiography. - **Healthy Diet**: Low-salt, low-saturated-fat, high-fiber diet; Mediterranean diet is ideal. - **Physical Activity**: Gradual return to exercise; cardiac rehabilitation program if referred. - **Diabetes Control**: Monitor glucose; take medications as prescribed. - **Lipid Management**: Take statin or other lipid-lowering drugs as ordered. - **Stress Reduction**: Relaxation techniques, meditation, counseling as needed. - **Follow-Up Care**: Schedule follow-up appointment with cardiologist in 1–2 weeks. Attend cardiac rehabilitation if referred. Bring a list of all medications and any questions to the next appointment.